On July 3, Wang Mingrui, chief analyst of the pharmaceutical industry at Everbright Securities Research Institute, said during the China Securities News “China Securities Dianjinhui” live broadcast that investment in the pharmaceutical sector in the second half of the year could focus on three major directions. The first is to innovate the industrial chain. The upward cycle of the domestic innovation industry chain unfolds on an annual basis, and we can continue to focus on this direction. The second is the direction of consumer medicine that is in line with the expanding needs of the masses. As the population structure changes and disease spectrum changes, the medical needs of the public will continue to expand. Baby boomers, for example, are about to enter retirement, and demand for medical expenses will rise after retirement. We can focus on the direction of matching domestic demand expansion, such as household medical devices, blood products, etc. The third is an internal circulation safe-haven asset. In order to cope with the uncertainty of the future international situation, assets with internal circulation properties may show immediate characteristics under specific circumstances.

On July 3, Wang Mingrui, chief analyst of the pharmaceutical industry at Everbright Securities Research Institute, said during the China Securities News “China Securities Dianjinhui” live broadcast that investment in the pharmaceutical sector in the second half of the year could focus on three major directions. The first is to innovate the industrial chain. The upward cycle of the domestic innovation industry chain unfolds on an annual basis, and we can continue to focus on this direction. The second is the direction of consumer medicine that is in line with the expanding needs of the masses. As the population structure changes and disease spectrum changes, the medical needs of the public will continue to expand. Baby boomers, for example, are about to enter retirement, and demand for medical expenses will rise after retirement. We can focus on the direction of matching domestic demand expansion, such as household medical devices, blood products, etc. The third is an internal circulation safe-haven asset. In order to cope with the uncertainty of the future international situation, assets with internal circulation properties may show immediate characteristics under specific circumstances.